What Therapists Need to Know About Psychopharmacology During COVID

This On Demand Training is 3 hours. This webinar was broadcasted live on Thursday, April 29, 2021

Already registered? Click here to access CEU information, handouts and recordings.

The COVID-19 pandemic is a particularly relevant threat to people with mental health challenges. Uncertainty and anxiety, social distancing/isolation, loneliness, and economic repercussions can greatly exacerbate an existing condition. At the same time, the long-term side effects of psychotropic drugs, physical health problems, substance use disorders, and medication non-adherence are also being observed during COVID-19.

Mental health professionals without medical training often see clients on multiple medications that can influence behaviour, response to interventions, and the ability to succeed in therapy. Furthermore, clients often do not fully understand why they are taking their medications and may even be unclear about who prescribed them in the first place. Despite the confusion, you still have a responsibility to know the symptoms and reactions to your clients’ medications, as well as to coordinate their care.

In this workshop, Kenneth Carter will give a thorough overview of psychopharmacology basics, with a focus on the most widely prescribed medications now. This knowledge will enable you to advocate effectively and safely for your clients. Kenneth will also share the latest information about the therapeutic effects, strengths, and possible problems associated with the most commonly prescribed medications, such as those used to treat depression, anxiety, and insomnia. You will learn how medications work and will be made aware of their official health warnings. You will also have a chance to explore the ethical decisions that surround the use of psychotropic medications. What’s more, you’ll hear about Psychopharmacology during COVID.

After this dynamic training, you will be more equipped to support and educate your clients and better able to communicate with prescribing medical professionals.

By the end of this training, attendees will be better able to—

  • Identify the proper role of mental health professionals who treat clients receiving both psychotherapeutic medications and psychotherapy.
  • Describe specific ethical issues and resolutions related to communicating with clients and prescribing professionals about psychotropic medications.
  • Identify the major classes of drugs used to treat depression, anxiety, and insomnia.

Kenneth Carter, PhD, ABPP, is a board-certified clinical psychologist and professor of psychology at Oxford College of Emory University in Atlanta, Georgia. Dr. Carter received his MA and PhD in clinical psychology from the University of Michigan in Ann Arbor and a postdoctoral master’s degree in clinical psychopharmacology from Fairleigh Dickerson University. Dr. Carter has taught clinical psychopharmacology classes at Emory University since 2005 and has presented highly rated Psychopharmacology workshops to clinicians throughout the United States since 2010. 

Dr. Carter has served as a senior assistant research scientist in the Epidemic Intelligence Service of the Centers for Disease Control and Prevention. He has been a psychotherapist and researcher for more than 20 years, during which time he has garnered awards from the National Institutes of Health, the National Heart, Lung and Blood Institute, and the University of Michigan.  Dr. Carter has presented at numerous conferences and written several books and articles on introductory psychology, neuropsychology, and psychopharmacology.

For more information, see www.drkencarter.com.

Time Topics Covered
First 90 mins
  • Psychopharmacology Ethics
  • Psychopharmacology Guidelines
  • Introductory Neuroscience
15 min break
  • 15 min break
Last 90 mins
  • Medicines for Depression, Anxiety, Insomnia
  • How COVID 19 Impacts Psychopharmacology

This training offers 3 hours of direct contact (not counting breaks or lunch). It is the participant’s responsibility to check with their individual state boards/regulatory body to verify CE requirements for their license to practice.

For Attendees of On Demand/Recorded Version

If you are watching the On Demand/recorded version of this webinar, you will need to complete a Post-Webinar Quiz with a pass of at least 80% in order to verify your attendance.

For US Participants

Instructions on how to obtain your Certificate of Attendance showing the hours completed will be distributed either following the Live Broadcast or with On-Demand registration (On-Demand participants must pass a post-webinar attendance quiz).  A CE package will be available which includes the full webinar description and details, the speaker’s CV and references.

For Canadian and International participants

Upon fulfillment of the above requirements, Canadian and international participants will be issued a Certificate of Participation which features:

  • Name of Participant
  • Title of Training
  • Name of Presenter plus their credentials
  • Number of hours of training
  • Date of training
  • Confirmation that you have passed a quiz with at least 80% grade to verify your attendance

Please check carefully with your regulating body/organization that this certificate is sufficient proof for you to claim CEUs.

For general information about Continuing Education for Canadians and International participants, please click here.  

This training is aimed at all mental health professionals including:

  • social workers
  • counsellors
  • psychologists
  • psychiatrists
  • medical professionals supporting mental health patients
  • psychotherapists
  • mental health counsellors
  • marriage and family therapists and counsellors
  • occupational therapists
  • vocational rehabilitation therapists
  • addiction counsellors
  • religious counsellors
  • therapists
  • case managers
  • art therapists
  • licensed professional counsellors
  • all other professionals who would like to develop, update or expand their skills and knowledge in mental health practices
Webinar Rate CAD$139.00 (USD$110)
Register for webinar